Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen

Aggarwal, Charu ; Gupta, Sameer ; Vaughan, William P. ; Saylors, Gene B. ; Salzman, Donna E. ; Katz, Rhonda O. ; Nance, Amy G. ; Tilden, Arabella B. ; Carabasi, Matthew H.

Biology of blood and marrow transplantation, 2006-07, Vol.12 (7), p.770-777

United States: Elsevier Inc

Texto completo disponível